Moolec Science (MLEC) Invested Capital (2022 - 2025)
Moolec Science (MLEC) reported Invested Capital of $246.8 million for Q2 2025, down 45.06% on a YoY basis from $449.1 million in Q2 2024, and up 1173.81% sequentially from $19.4 million in Q4 2024.
Moolec Science (MLEC) Invested Capital (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Invested Capital data on file, last reported at $246.8 million in Q2 2025.
- For the quarter ending Q2 2025, Invested Capital fell 45.06% year-over-year to $246.8 million; the trailing twelve-month figure through Mar 2026 stood at $266.1 million (changed N/A YoY), and the FY2025 full-year result was $246.8 million, down 45.06% from the prior year.
- Invested Capital grew to $246.8 million in Q2 2025, from $19.4 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $449.1 million in Q2 2024 to a low of $2.4 million in Q3 2023.
- A 4-year average of $155.6 million and a median of $19.4 million in 2024 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital soared 661.63% in 2024 and plunged 45.06% in 2025, its largest moves.
- Tracing MLEC's Invested Capital over 4 years: stood at $236.3 million in 2022, then tumbled by 97.62% to $5.6 million in 2023, then surged by 244.83% to $19.4 million in 2024, then jumped by 1173.81% to $246.8 million in 2025.
- Business Quant data shows MLEC's Invested Capital at $246.8 million in Q2 2025, $19.4 million in Q4 2024, and $18.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 246.76 Mn |
| Dec 31, 2024 | 19.37 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 449.15 Mn |
| Mar 31, 2024 | 10.61 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 412.22 Mn |
| Jun 30, 2022 | 236.31 Mn |